Revolution Medicines Inc.-28RVMDWPreferred / convertible
13F holders, Q1 2026 (March 31)23holders −1
2new positions
3sold out
1famous investor
$1.80avg. 13F price*
At the end of Q1 2026, 23 institutions reported holding Revolution Medicines Inc.-28 (RVMDW) in their 13F filings, down 1 from Q4 2025. 2 opened new positions and 3 sold out. The largest holders were LMR Partners LLP ($6.9M), D. E. Shaw & Co. ($2.7M) and Sculptor Capital LP ($1.7M). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Revolution Medicines Inc.-28
- CUSIP
- 76155X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $6K |
| Exits | 3 | $372K |
All 13F filers, Q4 2025 → Q1 2026: 2,029,130 shares bought and 682,560 shares sold, net +1,346,570 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| LMR Partners LLP | — | Add +21.8% | 3,838,024 | $6.9M |
| D. E. Shaw & Co. | — | Add +8.6% | 1,580,345 | $2.7M |
| Sculptor Capital LP | — | Add +438.3% | 958,822 | $1.7M |
| Aristeia Capital, L.L.C. | — | Reduce -6.6% | 583,615 | $1.0M |
| T. Rowe Price Associates Inc. | — | Reduce -2.8% | 579,550 | $1.0M |
| Caption Management, LLC | — | Add +417.7% | 517,685 | $927K |
| Adage Capital Partners Gp, L.L.C. | — | No change | 500,000 | $895K |
| Lunate Capital Ltd | — | No change | 450,000 | $806K |
| Perceptive Advisors LLC | — | No change | 250,000 | $448K |
| Bleichroeder LP | — | No change | 200,000 | $358K |
| Wolverine Asset Management LLC | — | Add +10.2% | 170,698 | $306K |
| CSS LLC | — | Reduce -10.0% | 17,505 | $282K |
| Davidson Kempner Capital Management LP | — | No change | 150,000 | $261K |
| Farallon Capital Management, L.L.C. | — | No change | 120,085 | $209K |
| Weiss Asset Management LP | — | No change | 73,640 | $128K |
| TD Asset Management Inc | — | No change | 40,636 | $71K |
| Driehaus Capital Management LLC | — | Reduce -85.2% | 20,000 | $35K |
| Toronto Dominion Bank | — | Reduce -91.8% | 10,000 | $18K |
| Morgan Stanley | — | New | 2,216 | $4K |
| UBS Group AG | — | New | 886 | $2K |
| TD Waterhouse Canada Inc. | — | No change | 448 | $790 |
| Osaic Holdings, Inc. | — | Add +50.0% | 90 | $161 |
| Royal Bank of Canada | — | No change | 200 | $0 |
"% of holder's portfolio" is RVMDW's weight in each manager's 13F, not the share of Revolution Medicines Inc.-28 the manager owns.